Peng Guo1, Rui-Dan Wang1, Teng-Hong Lian1, Du-Yu Ding1, Ya-Nan Zhang2, Wei-Jiao Zhang1, Dan-Ning Li1, Li-Xia Li3, Jing-Hui Li1, Hui-Ying Guan1, Shu-Yang Yu1, Li Liu3, Yang Hu1, Li-Jun Zuo1, Qiu-Jin Yu1, Xiao-Min Wang4, Wei Zhang5,6,7,8. 1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 2. Department of Blood Transfusion, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 3. Department of General Internal Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 4. Department of Physiology, Capital Medical University, Beijing, China. 5. Department of Neurology, Center for Cognitive Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 6. China National Clinical Research Center for Neurological Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. 7. Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, China. 8. Beijing Key Laboratory on Parkinson Disease, Beijing, China.
Abstract
Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear. Methods: 166 PD patients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PD patients. The levels of neuropathologic proteins, including α-Synuclein, Aβ1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay. Results: out of the 166 PD patients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). α-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). Aβ1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF. Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of α-Synuclein and the decrease of the T-tau level in CSF.
Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PDpatients remains unclear. Methods: 166 PDpatients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PDpatients. The levels of neuropathologic proteins, including α-Synuclein, Aβ1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay. Results: out of the 166 PDpatients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). α-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). Aβ1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF. Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of α-Synuclein and the decrease of the T-tau level in CSF.
Authors: Michelle E Fullard; Baochan Tran; Lama M Chahine; James F Morley; Sharon X Xie; Jon B Toledo; Christi Scordia; Carly Linder; Rachael Purri; Daniel Weintraub; John E Duda Journal: Parkinsonism Relat Disord Date: 2016-02-19 Impact factor: 4.891
Authors: Robert S Wilson; Lei Yu; Julie A Schneider; Steven E Arnold; Aron S Buchman; David A Bennett Journal: Chem Senses Date: 2011-01-21 Impact factor: 3.160
Authors: Li Jun Zuo; Shu Yang Yu; Fang Wang; Yang Hu; Ying Shan Piao; Yang Du; Teng Hong Lian; Rui Dan Wang; Qiu Jin Yu; Ya Jie Wang; Xiao Min Wang; Piu Chan; Sheng Di Chen; Yongjun Wang; Wei Zhang Journal: J Clin Neurol Date: 2016-02-04 Impact factor: 3.077
Authors: Lucilla Parnetti; Davide Chiasserini; Emanuele Persichetti; Paolo Eusebi; Shiji Varghese; Mohammad M Qureshi; Andrea Dardis; Marta Deganuto; Claudia De Carlo; Anna Castrioto; Chiara Balducci; Silvia Paciotti; Nicola Tambasco; Bruno Bembi; Laura Bonanni; Marco Onofrj; Aroldo Rossi; Tommaso Beccari; Omar El-Agnaf; Paolo Calabresi Journal: Mov Disord Date: 2014-01-16 Impact factor: 10.338
Authors: Xiuli Dan; Noah Wechter; Samuel Gray; Joy G Mohanty; Deborah L Croteau; Vilhelm A Bohr Journal: Ageing Res Rev Date: 2021-07-27 Impact factor: 11.788